EZYCUT

Main information

  • Trade name:
  • EZYCUT AMP INJ
  • Dosage:
  • 1.5MG/ML
  • Pharmaceutical form:
  • INJ
  • Composition:
  • AMP
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EZYCUT AMP INJ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

5-5-2017

FDA approves drug to treat ALS

FDA approves drug to treat ALS

The U.S. Food and Drug Administration today approved Radicava (edaravone) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease.

FDA - U.S. Food and Drug Administration

22-5-2017

RADICAVA (Edaravone) Injection [MT Pharma America, Inc.]

RADICAVA (Edaravone) Injection [MT Pharma America, Inc.]

Updated Date: May 22, 2017 EST

US - DailyMed

5-5-2017

FDA Approves Edaravone (Radicava) for ALS

FDA Approves Edaravone (Radicava) for ALS

The US Food and Drug Administration (FDA) today approved the drug  edaravone (Radicava, Mitsubishi Tanabe Pharma America) to slow down functional decline in patients with amyotrophic lateral sclerosis (ALS).

US - RxList